ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NKTR Nektar Therapeutics

1.33
0.01 (0.76%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Nektar Therapeutics NKTR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.76% 1.33 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.33 1.31 1.38 1.33 1.32
more quote information »

Recent News

Date Time Source Heading
23/3/202405:00PRNUSNektar Management to Present at the H.C. Wainwright 2nd..
06/3/202409:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202401:00PRNUSNektar Therapeutics Announces Initiation of Phase 2b..
05/3/202408:20EDGAR2Form 8-K - Current report
05/3/202408:15PRNUSNektar Therapeutics Reports Fourth Quarter and Year-End 2023..
05/3/202400:40EDGAR2Form 8-K - Current report
05/3/202400:30PRNUSNektar Therapeutics Announces $30 Million Private Placement..
28/2/202410:00PRNUSNektar Management to Present at the TD Cowen 44th Annual..
27/2/202410:00PRNUSNektar to Announce Financial Results for the Fourth Quarter..
23/2/202412:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202407:55EDGAR2Form 144 - Report of proposed sale of securities
21/2/202407:51EDGAR2Form 144 - Report of proposed sale of securities
21/2/202407:50EDGAR2Form 144 - Report of proposed sale of securities
17/2/202409:16EDGAR2Form 8-K - Current report
15/2/202409:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202400:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202408:25EDGAR2Form 8-K - Current report
04/1/202410:00PRNUSNektar Management To Present at the 42nd Annual J.P. Morgan..
16/12/202310:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202304:18EDGAR2Form 144 - Report of proposed sale of securities
12/12/202310:00PRNUSNektar and Collaborators Present Preclinical Data on..
28/11/202308:55EDGAR2Form 8-K - Current report
21/11/202313:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202312:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202308:36EDGAR2Form 144 - Report of proposed sale of securities
18/11/202308:15EDGAR2Form 144 - Report of proposed sale of securities
18/11/202308:10EDGAR2Form 144 - Report of proposed sale of securities
08/11/202308:21EDGAR2Form 8-K - Current report
08/11/202308:15PRNUSNektar Therapeutics Reports Third Quarter 2023 Financial..
01/11/202309:00PRNUSNektar to Announce Financial Results for the Third Quarter..
13/10/202323:30PRNUSNektar Presents New Responder Data for Rezpegaldesleukin, a..
03/10/202300:00PRNUSNektar Therapeutics Announces Two Abstracts Accepted at EADV..
27/9/202323:00PRNUSNektar Therapeutics Announces New Clinical Study..
22/9/202310:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202310:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202310:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202310:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202310:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202307:06EDGAR2Form 144 - Report of proposed sale of securities
13/9/202323:00PRNUSNektar Therapeutics Announces Promising New Data from Phase..
09/9/202307:16EDGAR2Form 8-K - Current report
07/9/202308:00PRNUSNektar Therapeutics to Host Virtual Investor & Analyst Event..
18/8/202310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202310:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock